Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanan Huo

Showing results (31-40 of 123) with videos related to

Pageof 13
Sort By:
Advances in Ophthalmology Practice and Research|September 19, 2024
Therapeutic effectiveness of different machines in intense pulsed light treatment of meibomian gland dysfunctionZhenwei Qin, Yirui Zhu, Jiale Lu, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 13, 2025
Combined inhibition of importin-β and PBR enhances osteogenic differentiation of BMSCs by reducing nuclear accumulation of glucocorticoid receptor and promoting its mitochondrial translocationYing Deng, Anhua Lin, Chunhong Lai, et al.
Kidney International|December 23, 2023
In vivo base editing rescues primary hyperoxaluria type 1 in ratsZhoutong Chen, Dexin Zhang, Rui Zheng, et al.
Clinical and Translational Medicine|November 23, 2025
LNP-mediated in vivo base editing corrects Agxt to cure primary hyperoxaluria type 1Dexin Zhang, Rui Zheng, Zhoutong Chen, et al.
Journal of Pain Research|April 10, 2025
Impact of Propranolol and Psychologically Informed Intervention on Pain Sensitivity: Secondary Analysis from the Biopsychosocial Influence on Shoulder Pain Preclinical Randomized TrialMark D Bishop, Corey B Simon, Yanan Huo, et al.
Science China. Life Sciences|October 19, 2024
Lipid nanoparticle-mediated base-editing of the Hao1 gene achieves sustainable primary hyperoxaluria type 1 therapy in ratsDexin Zhang, Rui Zheng, Zhoutong Chen, et al.
Blood Advances|August 30, 2024
Magrolimab plus rituximab in relapsed/refractory indolent non-Hodgkin lymphoma: 3-year follow-up of a phase 1/2 trialAmitkumar Mehta, Leslie Popplewell, Graham P Collins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 16, 2020
Amelioration of an Inherited Metabolic Liver Disease through Creation of a De Novo Start Codon by Cytidine Base EditingLei Yang, Liren Wang, Yanan Huo, et al.
Expert Opinion on Biological Therapy|May 16, 2024
Randomized, double-blind, placebo-controlled, multicenter study to evaluate efficacy and safety of the denosumab biosimilar MW031 in Chinese postmenopausal women with osteoporosisYan Jiang, Yanan Huo, Yufeng Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 2, 2022
Engineering of efficiency-enhanced Cas9 and base editors with improved gene therapy efficaciesShuming Yin, Mei Zhang, Yang Liu, et al.
Pageof 13

Showing results (31-40 of 123) with videos related to

Sort By:
Pageof 13
Advances in Ophthalmology Practice and Research|September 19, 2024
Therapeutic effectiveness of different machines in intense pulsed light treatment of meibomian gland dysfunctionZhenwei Qin, Yirui Zhu, Jiale Lu, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 13, 2025
Combined inhibition of importin-β and PBR enhances osteogenic differentiation of BMSCs by reducing nuclear accumulation of glucocorticoid receptor and promoting its mitochondrial translocationYing Deng, Anhua Lin, Chunhong Lai, et al.
Kidney International|December 23, 2023
In vivo base editing rescues primary hyperoxaluria type 1 in ratsZhoutong Chen, Dexin Zhang, Rui Zheng, et al.
Clinical and Translational Medicine|November 23, 2025
LNP-mediated in vivo base editing corrects Agxt to cure primary hyperoxaluria type 1Dexin Zhang, Rui Zheng, Zhoutong Chen, et al.
Journal of Pain Research|April 10, 2025
Impact of Propranolol and Psychologically Informed Intervention on Pain Sensitivity: Secondary Analysis from the Biopsychosocial Influence on Shoulder Pain Preclinical Randomized TrialMark D Bishop, Corey B Simon, Yanan Huo, et al.
Science China. Life Sciences|October 19, 2024
Lipid nanoparticle-mediated base-editing of the Hao1 gene achieves sustainable primary hyperoxaluria type 1 therapy in ratsDexin Zhang, Rui Zheng, Zhoutong Chen, et al.
Blood Advances|August 30, 2024
Magrolimab plus rituximab in relapsed/refractory indolent non-Hodgkin lymphoma: 3-year follow-up of a phase 1/2 trialAmitkumar Mehta, Leslie Popplewell, Graham P Collins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 16, 2020
Amelioration of an Inherited Metabolic Liver Disease through Creation of a De Novo Start Codon by Cytidine Base EditingLei Yang, Liren Wang, Yanan Huo, et al.
Expert Opinion on Biological Therapy|May 16, 2024
Randomized, double-blind, placebo-controlled, multicenter study to evaluate efficacy and safety of the denosumab biosimilar MW031 in Chinese postmenopausal women with osteoporosisYan Jiang, Yanan Huo, Yufeng Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 2, 2022
Engineering of efficiency-enhanced Cas9 and base editors with improved gene therapy efficaciesShuming Yin, Mei Zhang, Yang Liu, et al.
Pageof 13